Search Results 151-160 of 17051 for monoclonal antibody

1. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Prior anti-cancer monoclonal antibody (mAb) =< 4 weeks prior to registration ...

2. Tackling the latest COVID-19 topics - Mayo Clinic News Network

   Antibody tests after having a COVID-19 vaccine. Monoclonal antibodies. COVID-19 variants. Side effects, especially after the second dose of a COVID-19 ...

3. Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers - Mayo Clinic

   Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore ...

4. Elranatamab-bcmm (subcutaneous route) - Mayo Clinic

   These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

5. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Monoclonal antibodies can block cancer growth in different ways. ... Prior anti-cancer monoclonal antibody < 28 days prior to registration or who ...

6. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   About this study. RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to ...

7. Cancer Clinical Trials - Medical Professionals

   ... monoclonal antibody, and compare them with clinical outcomes. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now. Rochester ...

8. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

   Bortezomib may also stop the growth of cancer cells by blocking blood flow to the tumor. Monoclonal antibodies, such as rituximab, can block cancer growth ... A ...

9. Covering COVID-19 in 2021 - Mayo Clinic News Network

   Now we have three vaccines in the U.S., and antiviral and monoclonal antibody treatments. That's really incredible." Despite the rapid scientific ...

10. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...